20.25
price down icon2.88%   -0.60
after-market Handel nachbörslich: 20.25
loading

Dianthus Therapeutics Inc Aktie (DNTH) Neueste Nachrichten

pulisher
08:37 AM

HC Wainwright Has Bearish Forecast for DNTH Q3 Earnings - MarketBeat

08:37 AM
pulisher
07:13 AM

Guggenheim reiterates Buy rating on Dianthus Therapeutics stock ahead of trial data - Investing.com Canada

07:13 AM
pulisher
07:11 AM

Is this a good reentry point in Dianthus Therapeutics Inc.Earnings Growth Report & Precise Swing Trade Entry Alerts - Newser

07:11 AM
pulisher
04:27 AM

Can trapped investors hope for a rebound in Dianthus Therapeutics Inc.2025 Risk Factors & Trade Opportunity Analysis Reports - Newser

04:27 AM
pulisher
02:13 AM

Equities Analysts Set Expectations for DNTH FY2025 Earnings - Defense World

02:13 AM
pulisher
01:53 AM

HC Wainwright Has Pessimistic Outlook of DNTH Q3 Earnings - Defense World

01:53 AM
pulisher
01:32 AM

Can you recover from losses in Dianthus Therapeutics Inc.2025 Short Interest & Fast Gaining Stock Reports - Newser

01:32 AM
pulisher
Aug 13, 2025

How to forecast Dianthus Therapeutics Inc. trends using time seriesPortfolio Risk Report & Daily Chart Pattern Signal Reports - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Dianthus Therapeutics Inc.’s volatility index tracking explainedAnalyst Upgrade & Growth Oriented Trading Recommendations - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Dianthus Therapeutics Inc. stock trend forecast2025 Year in Review & Real-Time Stock Entry Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

What earnings revisions data tells us about Dianthus Therapeutics Inc.2025 Key Lessons & Breakout Confirmation Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Real time breakdown of Dianthus Therapeutics Inc. stock performancePortfolio Risk Summary & Technical Entry and Exit Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives $53.00 Consensus Target Price from Brokerages - MarketBeat

Aug 13, 2025
pulisher
Aug 13, 2025

Backtesting results for Dianthus Therapeutics Inc. trading strategiesWeekly Stock Recap & Precise Entry and Exit Recommendations - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Can you recover from losses in Dianthus Therapeutics Inc. [Quarterly Performance Summary]Free Reliable Trade Execution Plans - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How institutional ownership impacts Dianthus Therapeutics Inc. stock [July 2025 Rallies]Free Community Verified Trade Signals - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Is Dianthus Therapeutics Inc. stock poised for growthMarket Activity Recap & Risk Controlled Stock Pick Alerts - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Custom watchlist performance reports with Dianthus Therapeutics Inc.Strong Buy Opportunity with Volume Support - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

What is William Blair's Estimate for DNTH Q1 Earnings? - MarketBeat

Aug 12, 2025
pulisher
Aug 12, 2025

Relative strength of Dianthus Therapeutics Inc. in sector analysisDay Trading Plan with Entry Risk Management - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Has Dianthus Therapeutics Inc. formed a bullish divergenceDay Trading Setup and Momentum Analysis - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

How moving averages guide Dianthus Therapeutics Inc. tradingFree Triple Return Setup with Risk Control - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

How institutional ownership impacts Dianthus Therapeutics Inc. stockDaily Profit Watch With Forecast Confidence - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Will earnings trigger a reversal in Dianthus Therapeutics Inc.Predictable Income Summary for Long-Term Trades - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Dianthus Therapeutics (DNTH) to Release Earnings on Thursday - MarketBeat

Aug 10, 2025
pulisher
Aug 10, 2025

Key External Factors That Drive Dianthus Therapeutics Inc. Stock Price MovementsValue Holding Return Summary With Outlook - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Why Dianthus Therapeutics Inc. stock attracts strong analyst attentionFree Accurate Buy Point for Momentum Stocks - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

What makes Dianthus Therapeutics Inc. stock price move sharplyFree Consistent Gain Investment Strategies - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Aug 09, 2025
pulisher
Aug 08, 2025

Is Dianthus Therapeutics Inc. still worth holding after the dipFree Reliable Investment Entry Point Signals - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Lags Revenue Estimates - NewsBreak: Local News & Alerts

Aug 08, 2025
pulisher
Aug 08, 2025

Dianthus Therapeutics Reports Q2 2025 Financial Results - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Earnings Preview: Dianthus Therapeutics, Inc. (DNTH) Q2 Earnings Expected to Decline - NewsBreak: Local News & Alerts

Aug 08, 2025
pulisher
Aug 07, 2025

Dianthus Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

TD Cowen Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating - 富途牛牛

Aug 07, 2025
pulisher
Aug 07, 2025

Promising Outlook for Dianthus Therapeutics: Buy Rating on Claseprubart’s Potential in gMG - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Dianthus Therapeutics: Promising Prospects with DNTH103 and Strong Financial Position Support Buy Rating - TipRanks

Aug 07, 2025
$36.50
price up icon 0.11%
$86.16
price up icon 0.36%
$26.45
price down icon 1.56%
$127.75
price up icon 3.97%
$112.70
price down icon 0.07%
biotechnology ONC
$309.69
price up icon 0.71%
Kapitalisierung:     |  Volumen (24h):